Covered recipient · General Payments record
AUDREY ANN MCGINNIS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2025
$1,187.92
- Reported across 39 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.45 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $101.09 | 5 |
| Novo Nordisk AS | $58.23 | 3 |
| Lilly USA, LLC | $54.58 | 3 |
| Amgen Inc. | $44.21 | 3 |
| PFIZER INC. | $42.93 | 2 |
| GlaxoSmithKline, LLC. | $17.96 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.31 | 01/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204888340 | CMS |
| ABBVIE INC. | $15.06 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204888344 | CMS |
| ABBVIE INC. | $19.71 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204888348 | CMS |
| ABBVIE INC. | $18.08 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204888351 | CMS |
| ABBVIE INC. | $25.93 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204888356 | CMS |
| Amgen Inc. | $15.48 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228998263 | CMS |
| Amgen Inc. | $14.32 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228998257 | CMS |
| Amgen Inc. | $14.41 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228998273 | CMS |
| GlaxoSmithKline, LLC. | $17.96 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190743341 | CMS |
| Lilly USA, LLC | $17.18 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187013902 | CMS |
| Lilly USA, LLC | $18.08 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187013904 | CMS |
| Lilly USA, LLC | $19.32 | 07/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187001932 | CMS |
| Novo Nordisk Inc | $14.87 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189103342 | CMS |
| Novo Nordisk Inc | $20.66 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188786709 | CMS |
| Novo Nordisk Inc | $22.70 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188378075 | CMS |
| PFIZER INC. | $18.06 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231512973 | CMS |
| PFIZER INC. | $24.87 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228823429 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.45 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232039150 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.